Cryoablation Combined With Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma

Clinical trial NCT04724226 · UNKNOWN

Trial details

NCT number: NCT04724226
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2021-09-01
Primary completion: 2023-08-31
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.